Valens SVP exercises options, sells 4,000 shares
Valens Semiconductor Ltd. senior vice president of R&D Chairman David reported a routine exercise-and-sell transaction in company shares.
Rhea-AI Filing Summary
Valens Semiconductor Ltd. senior vice president of R&D Chairman David reported a routine exercise-and-sell transaction in company shares. On May 8, 2026, he exercised 4,000 stock options at $0.86 per share, acquiring the same number of ordinary shares. Those 4,000 shares were then sold in an open-market transaction at a weighted average price of about $2.5431 per share under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, he directly holds 403,968 ordinary shares and 83,695 stock options, so the sale represents a small portion of his overall position.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 4,000 shares ($7K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Chairman David
Role
SVP, R&D
Sold
4,000 shs ($10K)
Approx. gross sale proceeds
$10K
Approx. exercise cost
$3K
Approx. pre-tax spread
$7K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 4,000 | $0.00 | $0.00 |
| Exercise | Ordinary Shares | 4,000 | $0.86 | $3K |
| Sale | Ordinary Shares | 4,000 | $2.5431 | $10K |
Holdings After Transaction:
Stock Option (Right to Buy) — 83,695 contracts (Direct);
Ordinary Shares — 403,968 shares (Direct)
Footnotes (5)
- F1. The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024
- F2. The shares sold were acquired upon the exercise of stock options on the same date
- F3. The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.
- F4. The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.
- F5. The shares were acquired upon the exercise of stock options
Key Figures
Shares sold: 4,000 shares
Sale price: $2.5431 per share
Options exercised: 4,000 options
+4 more
7 metrics
Shares sold
4,000 shares
Ordinary shares sold on May 8, 2026
Sale price
$2.5431 per share
Weighted average sale price for 4,000 shares
Options exercised
4,000 options
Stock options exercised into ordinary shares
Exercise price
$0.86 per share
Conversion or exercise price of stock options
Shares owned after
403,968 shares
Direct ordinary share holdings post-transaction
Options remaining
83,695 options
Stock options outstanding after exercise
Option expiration
June 9, 2031
Expiration date of the reported stock options
Key Terms
Rule 10b5-1 trading plan, weighted average price, Stock Option (Right to Buy), Ordinary Shares
4 terms
Rule 10b5-1 trading plan regulatory
"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) transaction with 4,000.0000 shares"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Valens Semiconductor (VLN) report for Chairman David?
Valens Semiconductor reported that SVP R&D Chairman David exercised 4,000 stock options and sold 4,000 ordinary shares. The exercise occurred at $0.86 per share and the sale at a weighted average price of $2.5431 per share on May 8, 2026, under a 10b5-1 plan.
What options did the Valens Semiconductor (VLN) insider exercise in this Form 4?
Chairman David exercised 4,000 stock options with a conversion or exercise price of $0.86 per share. The options related to ordinary shares, and the exercise directly preceded the sale of the same 4,000 shares, as described in the transaction details and footnotes.
Were the Valens Semiconductor (VLN) insider sales part of a Rule 10b5-1 trading plan?
Yes. The Form 4 footnotes state that the sales were effectuated under a Rule 10b5-1 trading plan adopted on August 16, 2024. Such pre-arranged plans allow insiders to sell shares according to a predetermined schedule, reducing discretion over trade timing.
Does the Valens Semiconductor (VLN) insider still hold stock options after this exercise?
Yes. Following the 4,000-option exercise, Chairman David still holds 83,695 stock options. These remaining options relate to ordinary shares and have an expiration date of June 9, 2031, according to the derivative transaction data in the Form 4 filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
